Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Long-term use of ticagrelor in patients with prior myocardial infarction.

Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS; PEGASUS-TIMI 54 Steering Committee and Investigators.

N Engl J Med. 2015 May 7;372(19):1791-800. doi: 10.1056/NEJMoa1500857. Epub 2015 Mar 14.

2.

Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial.

Mega JL, Braunwald E, Mohanavelu S, Burton P, Poulter R, Misselwitz F, Hricak V, Barnathan ES, Bordes P, Witkowski A, Markov V, Oppenheimer L, Gibson CM; ATLAS ACS-TIMI 46 study group.

Lancet. 2009 Jul 4;374(9683):29-38. doi: 10.1016/S0140-6736(09)60738-8. Epub 2009 Jun 17.

PMID:
19539361
3.

Evidence of a long QT founder gene with varying phenotypic expression in South African families.

de Jager T, Corbett CH, Badenhorst JC, Brink PA, Corfield VA.

J Med Genet. 1996 Jul;33(7):567-73.

4.

NOTES ON THREE CASES OF TETANUS.

Douglas RI, Corbett CH.

Br Med J. 1917 Jan 27;1(2926):119-20. No abstract available.

5.

TYPHUS FEVER IN PALESTINE, 1913-14.

Corbett CH.

Br Med J. 1915 May 22;1(2838):887-8. No abstract available.

Supplemental Content

Loading ...
Support Center